Possible ovarian cancer treatment target identified

(Massachusetts General Hospital) A multi-institutional study has identified a potential personalized treatment target for the most common form of ovarian cancer. The research team discovered that a gene called MAGP2 not previously associated with any type of cancer was overexpressed in papillary serous ovarian tumors of patients who died more quickly. They also found evidence suggesting possible mechanisms by which MAGP2 may promote tumor growth.

source : www.eurekalert.org

Related News:

• MHNCS: PET May Predict Cancer Aggression (CME/CE)
• The 27th Annual Miami Breast Cancer Conference
• Predictive Biosciences To Present Novel Combination Approach To Molecular Cancer Diagnostics At 2010 Genitourinary Cancers Symposium
• Prolonged Use Of HRT Increases Incidence Of Lung Cancer By About 50 Percent: New Study
• UAB Cancer Center, Urologists Affirm Men Should Take Lead In Deciding Prostate Screening
• AUA Responds To American Cancer Society Guideline For The Early Detection Of Prostate Cancer
• National Healthcare Organization’s New Catheterization Resource Is Beneficial To Millions
• Dendreon Presents Updated IMPACT Results Confirming PROVENGE Improves Overall Survival In Patients With Metastatic Castrate-Resistant Prostate Cancer
• MHNCS: PET May Predict Cancer Aggression
• Experts Call For Further Research Into The Relationship Between Insulin Therapy And Cancer